ResMed Inc. (ASX: RMD) Share Price and News
Price
$37.83
Movement
0.16 (-0.42%)
As at 6 Nov 1:22pm (20 mins delayed)
52 Week Range
$32.04 - $45.25
1 Year Return
0.0
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
$37.83
Day Change
0.16 (-0.42%)
52 Week Range
$32.04 - $45.25
Yesterday's Close
$37.99
Today's Open
$38.23
Days Range
$37.72 - $38.29
Volume
666,579
Avg. Volume (1 month)
1,226,904
Turnover
$25,183,135
As at 6 Nov 1:22pm
ResMed Inc. (ASX: RMD)
Latest News
Broker Notes
Why this broker sees plenty of upside for the ResMed share price
Broker Notes
Leading brokers name 3 ASX shares to buy today
Healthcare Shares
The ASX 200 company selling everything it makes due to its major competitor being out of the market: fundie
Broker Notes
2 quality ASX shares Wilsons just bought
Healthcare Shares
Resmed share price dips despite profit and dividend boost
Share Fallers
Why Baby Bunting, PointsBet, ResMed, and Suncorp shares are dropping today
Earnings Results
ResMed share price on watch following solid FY22 growth
Share Market News
5 things to watch on the ASX 200 on Friday
Investing Strategies
$20,000 invested in these ASX shares 10 years ago is worth how much now?
Broker Notes
Brokers name 3 ASX shares to buy today
Broker Notes
Morgans names 3 more of the best ASX shares to buy in August
Growth Shares
Here are 3 stellar ASX growth shares analysts are tipping as buys
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.